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High-resolution ﬂow cytometryNano-sized extracelullar vesicles (EVs) released by various cell types play important roles in a plethora of
(patho)physiological processes and are increasingly recognized as biomarkers for disease. In addition,
engineered EV and EV-inspired liposomes hold great potential as drug delivery systems. Major technologies
developed for high-throughput analysis of individual EV include nanoparticle tracking analysis (NTA),
tunable resistive pulse sensing (tRPS) and high-resolution ﬂow cytometry (hFC). Currently, there is a
need for comparative studies on the available technologies to improve standardization of vesicle analysis in
diagnostic or therapeutic settings.
We investigated the possibilities, limitations and comparability of NTA, tRPS and hFC for analysis of tumor
cell-derived EVs and synthetic mimics (i.e. differently sized liposomes). NTA and tRPS instrument settings
were identiﬁed that signiﬁcantly affected the quantiﬁcation of these particles. Furthermore, we detailed the
differences in absolute quantiﬁcation of EVs and liposomes using the three technologies. This study increases
our understanding of possibilities and pitfalls of NTA, tRPS and hFC, which will beneﬁt standardized and
large-scale clinical application of (engineered) EVs and EV-mimics in the future.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Extracellular vesicles (EVs) are lipid membrane-enclosed vesicles
released by cells and present in bodily ﬂuids. EVs are heterogeneous in
composition and size, ranging from approximately 50 to 1000 nm,
with the vast majority b200 nm in size [1,2]. EVs originate from their
donor cell as a result of outward budding of the plasma membrane.
Alternatively, EVs form as a result of intracellular budding within late
endosomes, from which vesicles are released upon fusion of these
multivesicular bodies with the plasma membrane [3]. Regardless of
their size and origin, 'EVs' is the collective term adopted to designate
any type of cell-derived vesicle in the extracellular space. In recent
years, multiple reports have demonstrated EVs to play an important
role in (patho)physiological processes, such as immune responses [4],
blood coagulation [5], tissue repair [6] and tumor growth [7,8]. Currentistry & Cell Biology, Faculty of
CM Utrecht, The Netherlands.
en).
. This is an open access article underresearch focuses on obtaining improved insight into the formation and
function of EVs and on studying the potential of EVs formedical applica-
tions. One of these applications is to use EVs present in body ﬂuids as
biomarkers for diagnosis and monitoring of diseases [9,10]. In cancer,
tumor-derived EVs can serve as biomarkers since they contain proteins
and RNAs from their malignant donor cells [7,8]. Since tumor-derived
EVs are released in easily accessible bodily ﬂuids, such as blood or
urine [7,11], analysis of these EVs for disease monitoring may circum-
vent biopsies [11], thereby reducing biopsy related morbidity and mor-
tality. A second important application of EV in the medical ﬁeld is their
use as drug delivery systems. Although liposomes, which share the
bilayered membrane structure with EVs, have been employed as drug
delivery systems for many years, cross-pollination of knowledge in the
liposome and EV research ﬁelds now holds high promise for
improvement of current delivery systems. Various studies have indicated
that EVs can be exploited as carriers for delivery of exogenous therapeutic
cargoes, e.g. siRNAs, in vivo [12]. EV characteristics that facilitate efﬁcient
delivery of biological drugs include their capacity to traverse intact
biological barriers (e.g. blood–brain barrier) and to deliver functional
RNA into cells, as well as their stability in blood (reviewed in [13]).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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natural EV for drug delivery to speciﬁc tissues, or to design EV mimics
formulated as liposomes containing relevant EV components [14].
Even though EVs are increasingly recognized as important biological
and therapeutical entities, standardized methods for their analysis are
still lacking [15]. Establishment of suchmethods is crucial for safe appli-
cation of (engineered) EV in clinical practice, but EV quantiﬁcation has
proven technically difﬁcult due to the small size of EVs and their hetero-
geneity in size and composition.
In recent years, several instruments have become available
that allow detection and characterization of individual EVs. These
techniques include nanoparticle tracking analysis (NTA) [16,17],
tunable resistive pulse sensing (tRPS) [18] and high-resolution ﬂow
cytometry (hFC) [19]. EV detection and quantiﬁcation with these
single-particle analysis techniques rely on distinct principles. NTA is
based on the illumination of particles in suspension with a laser beam,
followed by the recording of the scattered light by a light-microscope.
The Brownian motion of each particle is individually tracked to deter-
mine the mean square displacement of the individual particle. Since
temperature and viscosity of the suspension are known and controlled,
the Stokes–Einstein equation can be used to determine the hydrody-
namic diameter of each individual particle. The total number of particles
is used for particle concentration estimation [16,20]. In tRPS, a non-
conductive polyurethane membrane, punctured to contain a single
opening, separates two ﬂuid cells [21]. By applying a voltage across
the membrane a ﬂow of ions is induced. Once a particle moves through
the nanopore, the ﬂow of ions is altered resulting in a brief “resistive
pulse” which is recorded by the instrument [22]. The size-distribution
[23] and concentration [24,25] of particles can be calculated by referring
the observed pulse height and rate to pulses induced by reference
particles of known volume and concentration. Flow cytometric analysis
of particles involves the sequential excitation of individual, ﬂuorescent-
ly labeled particles in a liquid stream and detection of emitted light by
diodes or photomultipliers [26]. In hFC, a high-end ﬂow cytometer is
optimized for the analysis of nano-particles. This optimization consists
of light scattering detection at customized angles, the usage of
high power lasers and high-performance photomultiplier tubes for
more sensitive light detection, and application of ﬂuorescence-based
thresholding to distinguish particles of interest from noise signals
[19]. In-depth description of the technical backgrounds of the tech-
niques is beyond the scope of this manuscript and described elsewhere
for NTA [16,20,27,28], tRPS [22–24] and hFC [19,29].
For accurate EV quantiﬁcation and characterization, it is impor-
tant to know to what extent instrument-speciﬁc variables inﬂuence
particle characterization. For NTA, studies on how instrument
settings affect the analysis of heterogeneous EV populations are lim-
ited [20,28,17], and the effects of speciﬁc variables on EV quantiﬁca-
tion and size-proﬁling by tRPS are largely unknown. For hFC, detailed
reports on optimizing the instrument conﬁguration and settings for
accurate analysis of EVs and other nano-sized particles have recently
been published [19,29]. In a few studies, two or three of the above
described techniques have been compared. However, these studies
either focused on size-proﬁling of synthetic beads [30,31], or did
not address effects of instrument settings on EV characterization
and quantiﬁcation [32,33].
Here, we report a comprehensive comparative study on NTA, tRPS
and hFC for analysis of populations of heterogeneous nano-sized EVs
and synthetic mimics (i.e. polystyrene beads and calcein-loaded
liposomes). We identiﬁed different NTA- and tRPS-variables that
signiﬁcantly inﬂuenced the quantiﬁcation of these particles. Further-
more, we assessed the comparability of NTA, tRPS and hFC in absolute
quantiﬁcation of liposomes and EVs. Based on these data, we stress
the importance of technical knowledge of the instruments, awareness
of analytical variables, and recognition of how instrument settings affect
measurements when analyzing EV populations with unknown concen-
tration and size heterogeneity.2. Materials and methods
2.1. Polystyrene beads
115 and 203 nmpolystyrene beads (Izon Science, Christchurch, New
Zealand) were analyzed using tRPS and NTA. For hFC, ﬂuorescent 100
and 200 nm polystyrene beads (yellow–green-ﬂuorescent FluoSpheres,
Invitrogen) were used.
2.2. Liposome preparation and characterization
Egg phosphatidylcholine (EPC), egg phosphatidylglycerol (EPG) (Li-
poid GmbH, Ludwigshafen, Germany) and cholesterol (Sigma-Aldrich
Chemie B.V., Zwijndrecht, The Netherlands) were dissolved in chloro-
form/methanol (1:1, v/v) in a round-bottom ﬂask in a molar ratio of
2:0.06:1, respectively. A lipid ﬁlm was prepared by rotary evaporation
(Rotavapor R3, Büchi Labortechnik AG, Flawil, Switzerland), followed
by drying under a stream of nitrogen. The lipid ﬁlm was hydrated
with 10 mM calcein for 105 nm liposomes or 250 μM calcein for
“L146” and “L212” liposomes in HEPES buffered saline (HBS, 10 mM
HEPES, 137 mM NaCl, pH 7.4). Liposomes were sized by multiple
extrusion under nitrogen pressure using polycarbonate membranes
(Nuclepore, Pleasanton, CA, USA) with pore sizes of 200 nm and
100 nm in a Lipex high pressure extruder (Lipex, Northern Lipids, Van-
couver, Canada) or a Liposofast Extruder (Avestin, Inc, Ottawa, Canada).
Non-entrapped calcein was removed with dialysis against HBS for at
least 3 days using Slide-A-Lyzer dialysis cassettes with a cut off of
10 kD (Thermo Scientiﬁc, Bremen, Germany). The mean particle size
of the liposomes and the polydispersity index (PDI) was determined
by means of dynamic light scattering (DLS) using a Malvern ALV CGS-3
with a He–Ne laser source (Malvern Instruments, Malvern, UK).
Liposome sizes (L146 and L212) were 146 nm with a PDI of 0.03 and
212 nmwith a PDI of 0.07. The zeta-potential of the liposomes (ζ poten-
tial) was determined using a Malvern Zetasizer Nano-Z (Malvern Instru-
ments, Malvern, UK). The phosphate concentrations of the liposomes
were determined with a phosphate assay described by Rouser et al.
[34]. For ﬁnal use, L146 and L212 liposomes were diluted with HBS till a
ﬁnal total lipid (including cholesterol) concentration of 65 mM.
2.3. Cell culture and EV isolation
The human glioblastoma cell line U87-MG and the lymphoblastoma
cell line RN were cultured in medium containing FCS depleted from
bovine EVs as described previously [18,19]. After 24 h of incubation
the supernatant was isolated and centrifuged at 200 ×g for 10 min,
two times at 500 ×g for 10 min, followed by 10,000 ×g for 30 min.
100,000×g pelleted EVswere resuspended in phosphate buffered saline
(PBS) containing 0.2% BSA from an ultracentrifuged stock solution [29].
EVs were ﬂuorescently labeled with 7.5 μM PKH67 (Sigma-Aldrich),
mixed with 2.5 M sucrose, overlaid with a linear sucrose gradient
(2.0–0.4 M sucrose in PBS) in an SW60 tube (Beckman) and ﬂoated
into the gradient by centrifugation for 16 h at 192,000 ×g [29]. Gradient
fractions were collected, diluted in PBS and analyzed. Fraction densities
were determined by refractometry.
2.4. NTA
An LM14 Nanosight instrument (Nanosight Ltd, Salisbury, UK)
equipped with a CMOS camera (Hamamatsu Photonics, Hamamatsu,
Japan) and a 488 nm laser was used. Data acquisition and processing
were performed usingNTA software 2.3 build 0025. Background extrac-
tionwas applied, and automatic settings were applied for theminimum
expected particle size, minimum track length and blur settings. Since
samples were diluted at least 20 times in PBS, viscosity settings for
water were applied and automatically corrected for the temperature
used. Detection threshold and camera level settings varied as described
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recorded and designated as a single measurement. Only measurements
with at least 1000 completed tracks were further analyzed [17]. For
polystyrene bead dilutions, single measurements were performed for
each dilution, whereas triplicates were recorded for liposome and EV
samples.
We excluded data obtained at camera-level 15 (shutter: 1200, gain:
500) as this camera-level resulted in the detection of substantial amounts
of background detection, obscuring accurate data interpretation.
2.5. tRPS
For tRPS, the qNano instrument (Izon Science Ltd, Christchurch, New
Zealand) was used as described [35]. Data was recorded and analyzed
using the Izon Control Suite Software version 2.2.2.111. The default
minimum blockade height (0.05 nA) for particle detection was used.
For sample calibration and serial dilution experiments, polystyrene
beads supplied by the qNano manufacturer were used. Both 115 and
203 nm polystyrene bead dilutions were recorded using NP100
nanopores. Liposome dilutions were recorded using two different
NP100 nanopores at 0.8 kPa and 1.2 kPa pressure settings. EV samples
were analyzed using both an NP200 (1.2 kPa pressure) and NP150
nanopore (1.4 kPa). The buffers of EVs and calibration beads were
kept identical by diluting the calibration beads in the appropriate
fraction of a (mock-loaded) sucrose-based density gradient.
2.6. hFC
High-resolution ﬂow cytometric analysis of individual EVs was
performed using the BD Inﬂux ﬂow cytometer (Becton Dickinson, San
Jose, CA, USA) with an optimized conﬁguration, as described in detail
before [29]. Light scattering was measured with a collection angle of
15–25° (reduced wide-angle FSC) and detection was performed in log
mode. Samples were run at low pressure (5 PSI on the sheath ﬂuid
and 4.2 PSI on the sample) using a 140 μm nozzle. The calculated ﬂow
rate at these settingswas 52.2 μl perminute, as determined byweighing
the volume aspirated during 30 min. Fluorescent 100 nm and 200 nm
polystyrene beads (yellow–green-ﬂuorescent FluoSpheres, Invitrogen)
were used for calibration of the ﬂuorescence, reduced wide-angle FSC,
and SSC settings. EVs in sucrose fractions were diluted in PBS at least
20 times and time-based quantitative measurements were performed
as described before [29]. Data was acquired using Spigot software ver-
sion 6.1 (Becton Dickinson). Data was further analyzed using FCS Ex-
press software (De Novo Software, Los Angeles, USA).
2.7. Statistical analysis
Data analysis was performed using Prism version 5.0 (GraphPad
Software, La Jolla, CA, USA) or Microsoft Excel 2010 (Microsoft, Seattle,
WA, USA). Two-tailed independent t-tests were used to test for
signiﬁcant differences in means. One-way ANOVA followed by Tukey's
post-test was performed to test differences between multiple groups.
Pearson's correlation coefﬁcient was used to determine the correlation
between dilution and the measured concentration. Signiﬁcance was
determined and indicated as (*) p-value ≤ 0.05, (**) p-value ≤ 0.01
and (***) p-value ≤ 0.001. Error bars represent the standard deviation
(s.d.) unless stated otherwise.
3. Results
3.1. NTA-based particle quantiﬁcation
Detection of nano-sized particles with NTA is inﬂuenced by two
parameters: the camera-level (shutter speed and camera gain), which
is set prior to data acquisition, and the detection threshold, i.e. the scat-
tering intensity threshold above which particles are traced (set at dataprocessing). Here, we tested how these parameters affected the quanti-
ﬁcation of nano-sized particles that differ in refractive index, size, and
heterogeneity.
First, we determined the accuracy for quantiﬁcation of homoge-
neous populations of 115 or 203 nm sized polystyrene beads, which
have a high refractive index (r.i.) and consequently cause extensive
light scattering. Within a 32-fold dilution range (0.9–29.0 × 108/ml)
the measured concentrations approximated the expected concentra-
tions for 115 and 203 nm beads (Fig. 1A) (R2: 0.969 and 0.998
respectively).
For the 115 nm beads we were also able to obtain valid measure-
ments (N1000 completed tracks) outside this range. However, the
resulting s-shaped curve (Fig. 1A) indicates an overestimation of parti-
cles below 0.9 × 108/ml and an underestimation above 29.0 × 108/ml,
resulting in decreased correlation accuracy (R2: 0.859 for all measure-
ments). Although the range of refractive indices that EVs can exhibit is
largely unknown, polystyrene beads most likely have an r.i. that is sub-
stantially higher than the r.i. of themajority of EVs [17]. Next, we tested
how camera level and detection threshold settings affect the quantiﬁca-
tion of calcein-labeled liposomes, which, similar to EVs, are enclosed by
a lipid bilayer. Movies were recorded, at camera level 6 (shutter: 150,
gain: 250), camera level 9 (shutter: 450, gain: 250), and camera level
12 (shutter: 600, gain: 350), which represent preprogrammed NTA
settings. After data acquisition each movie was processed at detection
threshold 4, 6, 8 and 10 (standard software setting).
As expected, at increased camera levels the particles appeared
brighter and increased detection was observed of weak-scattering
particles (Fig. 1B, top-panel). The number of detectable particles was
also increased by reducing the detection threshold (Fig. 1B, bottom-
panel) (A complete overview of screenshots at different camera levels
and detection thresholds is provided in Suppl. Fig. S1A). Numerical
analysis of these data revealed that the quantiﬁcation of liposomes is
signiﬁcantly inﬂuenced by the NTA settings, with measurement of
higher concentrations after increasing the camera level or decreasing
the detection threshold (Fig. 1C and Suppl. Fig. S1B). At both camera
levels 9 and 12, accurate linearity in measured concentration was
observed for multiple dilutions of liposomes (applying camera level 6
resulted in an inadequate number of completed tracks) (Fig. 1D).
Thus, relative comparison of liposome concentrations is feasible with
different NTA settings, but measurement of the exact concentration
strongly depends on the camera-level and detection threshold settings.
Of interest, the increased number of liposome detection after increasing
the camera level is not accompanied by increased detection of smaller
sized liposomes (Suppl. Fig. S1C). It has previously been suggested
that smaller particles may be over-scattered by larger particles, which
would especially occur after concentrating samples [17,36]. However,
this appears not to occur for liposomes (Suppl. Fig. S1D).
Next, we tested to what extent the camera-level and detection
threshold inﬂuence the quantiﬁcation of EVs, which are more variable
in size and r.i. than liposomes. For these experiments, we used EVs
derived from the RN lymphoblastoma and U87-MG glioblastoma cell
lines that were puriﬁed from contaminating protein aggregates by
sucrose density gradient ultracentrifugation. As expected, increasing
the camera level resulted in an increased brightness of detected parti-
cles (Suppl. Fig. S2A). Similar to the liposome analysis, different EV
quantiﬁcation data were obtained at different camera level settings
(Fig. 1E). A maximum fold change of 3 was observed (camera-level 6
versus 12 at detection threshold 10). The inﬂuence of detection thresh-
old on particle quantiﬁcation was less prominent for EVs compared to
liposomes (Fig. 1E and Suppl. Fig. S2B). Similar data were obtained for
the U87-MG derived EVs (data not shown). Sample dilution did not
signiﬁcantly inﬂuence measurement of the raw EV concentration (i.e.
the measured sample concentration multiplied by the dilution factor)
(Fig. 1F). This was corroborated by the observation that the size-
distributions and mode sizes were similar at the different dilutions
(Suppl. Fig. S2C and S2D). Thus, although EVs are more heterogeneous
Fig. 1. NTA-based quantiﬁcation of beads, liposomes and EVs. (A) Quantiﬁcation of 115 and 203 nm polystyrene beads. The measured concentration of the beads is plotted against the
expected concentration based on themanufacturer's supplied stock concentration. Detection was performed at camera level 5 (shutter: 100, gain: 200) for the 115 nm beads and camera
level 3 (shutter: 20, gain: 0) for the 203 nmbeads. (B–D)Quantiﬁcation of 115 nm-sized liposomes. The effect of camera level and detection thresholdwas assessed, demonstrating visual
differences in particle imaging (screenshots in (B)) as well as differences in the calculation of raw concentrations (C). Dilution of liposomes showed linearity with themeasured liposome
concentration, at camera levels 9 and 12 (D). (E–F)Quantiﬁcation of puriﬁedEVs. The effect of camera level and detection thresholdonquantiﬁcation of EVs (fromRN cells) is shown in (E).
The effect of sample dilution (1:20 and 1:100) on quantiﬁcation is shown in (F), with EVs included from RN cells and U87-MG cells, and analysis at three different camera levels. Data are
mean ± s.d. (n = 3).
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higher level of scattering did not substantially affect detection of neigh-
boring EVs.
In conclusion, camera-level and detection threshold variables were
found to affect the NTA-based quantiﬁcation of liposomes and EVs.
The inﬂuences were more profound for the relatively homogeneous
liposomes than for the heterogeneous EVs.3.2. tRPS-based particle quantiﬁcation
As an alternative to NTA, we tested tRPS for liposome and EV
quantiﬁcation, with a speciﬁc focus on establishing the most suitable
measurement conditions. As tRPS-based quantiﬁcation requires a linear
correlation between the particle count rate (particles per minute) and
the concentration of particles, we ﬁrst measured a dilution range of
polystyrene calibration beads. We observed linearity over a 64-folddilution range for the 115 nm beads (R2: 0.979) and over a 32-fold
range for the 203 nm beads (R2: 0.994) (Fig. 2A).
Particle detection above threshold levels is dependent on the block-
ade height (resistive pulse) generated by a particle moving through a
nanopore. This blockade height is determined by the particle's volume
relative to the volume of the nanopore opening, the applied voltage,
and buffer used. These parameters together determine a ‘tRPS setup’
and thus determine if particles surpass threshold levels (0.05 nA at
default software settings). High-sensitivity tRPS setups can be used to
detect the smallest particles. To obtain a high-sensitivity setup one
should apply a high voltage, low stretch (to establish aminimal opening
size of the nanopore) and a small nanopore (NP100/NP150) [32,35].
Nanopore characteristics are known to differ between individual
nanopores, as well as over time [37]. To assess the effect of this on
liposome quantiﬁcation, we compared three cases. First we compared
two new NP100 nanopores (setups #1 and #2). Subsequently, the
nanopore used for setup #1 was tested again after approximately 7 h
Fig. 2. tRPS-based particle quantiﬁcation. (A) Quantiﬁcation of 115 and 203 nm polystyrene calibration beads. As tRPS quantiﬁcation is based on the conversion of observed particle per
minute counts to that of polystyrene calibration beads of known concentration, the read-out is displayed as “particles perminute”. (B) Three tRPS setups displaying the observed blockade
heights for the same 115nmcalibration beads (left-panel). The dashed line illustrates thedetection threshold (both panels). Reconstruction of the recordeddata for beads and liposomes at
the three different setups (right-panel), illustrating that the lower detection limit is the highest for setup #3, followed by setups #1 and #2. Bin size 15 pA. (C) Representative liposome
size-distributions obtained at the three different tRPS setups (left-panel). For each of the three setups themeasured concentration was corrected for the dilution factor to obtain raw con-
centration estimations (n= 6) (right-panel). Bin size 5 nm. (D) Quantiﬁcation of serially diluted liposomes at two different pressure levels (n = 3). (E) Representative size-distribution
obtained for RN-derived EVs on an NP200 nanopore setup and an N150A nanopore. Bin size 5 nm. (F) Raw particle concentrations were determined for RN and U87-MG derived EVs at
both the NP200 and NP150 nanopore setups (n = 3). Data are mean ± s.d.
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settings were applied in all three cases. Measurement of 115 nm poly-
styrene beads for tRPS calibration showed different mode blockade
heights detected for setups #1, #2, and #3, with #2 N #1 N #3 (Fig. 2B,
left panel). This indicated that the lower detection limit, as determined
by the height of the calibration bead blockade relative to the threshold
level of 0.05 nA, was different at the different setups. This is illustrated
by reconstructing the mean blockade heights of 115 nm calibration
particles and liposomes for the three setups (Fig. 2B, right panel).
Using setup #3, the peaks of the 115 nm calibration particles are closer
to the detection threshold level. The lower detection limit in setup #3 is
therefore higher than in setups #1 and#2, implicating that the blockade
height induced by smaller liposomes may not surpass the detection
threshold. This could result in the detection of only larger-sized lipo-
somes. Secondly, these observed differences indicate that characteris-
tics of nanopores, such as resolution, may change over time.The variation in detectable size range for setups 1–3 resulted in
substantial differences in absolute quantiﬁcation of the liposomes
(difference setup #2 versus #3: 2.43 fold; Fig. 2C). Setup #3 allowed de-
tection of N80 nm liposomes only (Fig. 2C, left-panel), and consequently
yielded the lowest liposome quantiﬁcation. Differences in particle
concentration (1.43 fold) were also observed for setups #1 and #2,
despite the comparable efﬁciency in detection of small liposomes at
these setups (Fig. 2C, left-panel).
Besides absolute quantiﬁcation of liposomes, we also determined
how accurate a range of liposome dilutions could be quantiﬁed by
tRPS (Fig. 2D). An NP100 nanopore was used for this test, and we con-
comitantly investigatedwhether the pressure level inﬂuenced liposome
quantiﬁcation. For both applied pressure levels we observed accurate
detection and linearity over a 4-fold dilution range. Surprisingly, chang-
ing the applied pressure led to signiﬁcantly different liposome sizing
estimations (Suppl. Fig. 3A and B).
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(Fig. 2E) and U87-MG derived EVs resembled those obtained using the
NTA, with the majority of EVs being 100–200 nm in size. Similar to
whatwe observed forNTA, tRPS showed thepresence of a small number
of larger (200–600 nm) EVs. Due to the presence of large EVs, we tested
two larger nanopores (NP200 and NP150) for EV quantiﬁcation, to
reduce clogging events. Even though frequent nanopore clogging was
observed, overall particle detection was stable and reproducible for
each triplicate of sample measurements (Suppl. Fig. S4A). Applying
the NP150 nanopore, which theoretically allows for detection of
100–120 nm particles, yielded signiﬁcantly higher EV particle concen-
trations as compared to the measurement with the NP200 pore
(Fig. 2F) (difference RN-derived EVs 1.45 fold, U87-derived EVs 1.50
fold). The ability tomeasure smaller sized EVswith theNP150 nanopore
(Suppl. Fig. S4B), led to signiﬁcant differences in the calculated mean
and mode sizes of the EVs (e.g. mode sizes of 136.3 nm (NP200) and
117.8 nm (NP150) for RN-derived EVs) (Suppl. Fig. S4C).
In conclusion, quantiﬁcations of liposomes and EVs can differ
between (high sensitivity) nanopore setups and this ismost likely relat-
ed to the lower detection limit. Since the required lower detection limitFig. 3. hFC-based particle quantiﬁcation. (A) Quantiﬁcation of serially diluted 100 and 200 nm ﬂ
time window of 30 s. (B) Dotplots indicating that calcein-loaded liposomes can be detected ab
rescent noise events (left-panel) and that light scattering levels induced by these liposomes are
are themean number of liposomes detected in a ﬁxed timewindow of 30 s. (D) Dotplots indica
threshold (left panel) and that the FSC and SSC signals induced by these heterogeneous are high
to determine the raw concentration estimation. No statistical different raw concentration estimmay be unknown for liposomes and EVs, tRPS measurementmay result
in underestimation of the concentration.
3.3. hFC-based particle quantiﬁcation
Reliable quantiﬁcation of nano-sized particles using ﬂuorescence-
based hFC requires that sufﬁcient numbers of ﬂuorophores are associat-
ed to the particle to be detected above the ﬂuorescence threshold, and
that maximal sensitivity in ﬂuorescence detection is obtained. The
optimal conﬁguration and settings for quantitative and qualitative anal-
yses of nano-sized particles using the BD Inﬂux have been determined
previously [19,29]. Instrument settings that were found to affect EV
measurements included the nozzle size and the applied sample/sheath
ﬂuid pressure. Using the optimal settings, 100 nm ﬂuorescent
polystyrene beads were efﬁciently detected above background noise.
Furthermore, for a 16-fold dilution range, hFC accurately detected
sample dilutions for both 100 (R2: 1.00) and 200 nm(R2: 0.999)ﬂuores-
cent polystyrene beads (Fig. 3A).
Calcein labeled, 105 nm sized liposomes could also be detected
above the ﬂuorescence threshold (Fig. 3B). As expected, light scatteringuorescent polystyrene beads. Indicated are themean number of beads detected in a ﬁxed
ove the ﬂuorescence threshold (solid horizontal line) that excludes detection of non-ﬂuo-
low (right-panel). (C) Quantiﬁcation of serially diluted calcein-loaded liposomes. Indicated
ting that PKH-67 labeled RN-derived EVs can be detected above the ﬂuorescence detection
ly variable. (E) EVsweremeasured over an 8-fold range, and corrected for the dilution used
ations between the dilutions were observed. Data are mean ± s.d. (n = 3).
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not be discriminated from those generated by noise, indicating the need
for ﬂuorescence-based analysis (data not shown). Within the 16-fold
dilution range tested here, liposomes could be quantiﬁed with accurate
linearity (R2: 1.00) (Fig. 3C).
hFC-mediated detection of RN and U87-MG derived EVs relied on
ﬂuorescent labeling of EV and efﬁcient removal of unbound dye by
sucrose-gradient ultra-centrifugation [29] (Fig. 3D and Suppl. Fig. 5).
Although hFC does not allow for absolute size measurement of EV, var-
iation in size and composition of EV are reﬂected in the light scattering
(FSC and SSC) and ﬂuorescence signals observed. Similar to what was
observed in the NTA and tRPS measurements of the RN and U87-MG
derived EVs, hFC-based analysis also indicated substantial heterogene-
ity within these EV populations based on light scattering and PKH67
ﬂuorescence levels (Fig. 3D and Suppl. Fig. 5). Quantiﬁcation by hFC
indicated no signiﬁcant differences in the estimation of EV concentra-
tions over an 8-fold dilution range for both the RN and U87-derived
EVs (Fig. 3E).
In conclusion, once sufﬁcient numbers of ﬂuorophores are associated
to liposomes or EVs to allow their detection above theﬂuorescent thresh-
old, hFC can be used for accurate quantitative analysis of ﬂuorescently
labeled liposomes and EVs in a range of sample dilutions.
4. Comparison of liposome and EV quantiﬁcation using NTA, tRPS,
and hFC
For clinical application and research purposes, it is of utmost impor-
tance to reliably determine the concentrations of (engineered) EVs orFig. 4. Comparison of liposome and EV quantiﬁcation using NTA, tRPS and hFC. (A) Comparativ
Liposomeswere diluted tomatch the required sample concentrations for thedifferent instrumen
lines indicate liposome concentration calculations based on lipid composition, phosphate quan
line). Size-distributions for L146 and L212 liposomes as obtained byNTA (B) and tRPS (C). Bin siz
hFC (n = 3) at instrument speciﬁc concentrations, converted to raw concentration estimationsynthetic mimics. Ideally, measurements of identical samples with
different technologies should yield comparable quantitative data. We
therefore compared quantiﬁcation data obtained by NTA, tRPS, and
ﬂuorescence-based hFC. Based on the previous experiments, a single
setup was selected for each instrument. We performed measurements
on relatively homogeneous populations of calcein-loaded liposomes
with (DLS-based) sizes of 146 and 212 nm (referred to as L146 and
L212 respectively), and a more heterogeneous population of puriﬁed
and PKH67 labeled EVs. NTA camera-levels were selected based on the
visually brightest detection of particles, without the occurrence of abun-
dant over-scattering events. The tRPS settings were selected to allow for
the highest-sensitivity measurement. More speciﬁcally, L146 measure-
ments were performed with NTA camera-level 12/detection-threshold
4 and nanopore NP100. For L212, camera-level 9/detection-threshold 4
and nanopore NP150 were selected. The RN-EVs were analyzed using
NTA camera-level 12/detection-threshold 10 and an NP150 nanopore.
Optimized settings [19] were used for hFC, and hFC settings were iden-
tical for measurements of both liposome populations and EVs. On the
three instruments L146 liposomes were quantiﬁed within a 12.5 fold
difference (Fig. 4A, left-panel). The highest concentrations were mea-
sured with NTA (1.86 × 1014/ml), followed by tRPS (5.33 × 1013/ml),
and hFC (1.5 × 1013/ml). Also for the L212 liposomes, NTA measure-
ments yielded the highest concentrations (7.73 × 1013/ml), followed
by tRPS (3.27 × 1013/ml) and hFC (1.12 × 1013/ml) (Fig. 4A, right-
panel). Overall, the measured L212 concentrations on the three
instruments were within a narrower absolute fold-range (6.92). We
compared these quantiﬁcations with liposome concentration measure-
ments based ondynamic light scattering (DLS)-sizing, lipid composition,e quantitative analysis of L146 and L212 liposomes using the three instruments (n = 3).
ts afterwhichmeasured concentrationswere calculated to raw concentrations. Horizontal
tiﬁcation, and dynamic light scattering (DLS) sizing (dotted line) or NTA/tRPS sizing (solid
e 5 nm. (D) Comparative quantitative analysis of RN-derived EVs byNTA (n=4), tRPS and
s. Data are mean ± s.e.m.
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Using this method, the calculated liposome concentrations were
2.27 × 1013/ml for L146 and 7.46 × 1012/ml for L212 liposomes (dotted
horizontal lines in Fig. 4A). However, DLS is known to be heavily
inﬂuenced by outliers [30], whichmay result in overestimated sizemea-
surements. When replacing DLS size measurement with averaged
liposome sizing data obtained by NTA and tRPS (124 and 156 nm
for the L146 and L212 liposomes, respectively; Fig. 4B and C), the calcu-
lated liposome concentrationswere substantially higher (solid horizontal
lines in Fig. 4A) and were most similar to the concentrations obtained by
tRPS.
The absolute concentration measurements of EV on the three
instruments were within a smaller fold-range difference compared
to the measurements of liposomes (4.44 versus 6.92 (L146) or 12.5
(L212); Fig. 4D). Interestingly, quantiﬁcation of EVs by tRPS and
hFC yielded absolute particle concentrations in the same range
(1.01 × 109/ml and 1.40 × 109/ml). However, similar to the liposome
measurements, NTA yielded substantially higher values for the EV
concentrations (4.50 × 109/ml) (Fig. 4D).
In conclusion, the absolute quantiﬁcations as observed for both
homogeneous calcein-loaded liposomes and a puriﬁed population of
more heterogeneous, PKH67 labeled RN derived EVs differed signiﬁ-
cantly between the instruments. For liposomes, the difference in quan-
tiﬁcations between the instruments decreased when measuring
liposomes that were larger in size. The smallest difference in absolute
concentration measurements between the instruments was found
when measuring the more heterogeneous population of EVs, for
which tRPS and hFC yielded highly similar results.5. Discussion
Over the last decade, the interest in EVshas greatly intensiﬁeddue to
their proposed role in various biological processes and their potential as
biomarkers for disease and as drug delivery systems. Approaches for
accurate and standardized quantiﬁcation of such nano-particles
have not yet been established, but are crucial for safe application of
EV(-mimics) in clinical settings. Here, we compared quantiﬁcation of
different nano-sized particles, i.e. polystyrene beads, calcein-labeled
ﬂuorescent liposomes and puriﬁed, PKH67-labeled EVs using three
prominent single-EV analysis platforms; NTA, tRPS, and hFC. Moreover,
we identiﬁed variables that signiﬁcantly inﬂuenced particle quantiﬁca-
tion using NTA and tRPS.
The particle concentration range at which accurate quantiﬁcation
data could be obtained differed between the instruments. For NTA, the
optimal concentration range was 9.0 × 107/ml–2.9 × 109/ml, which is
a slightly larger dilution series than previously reported [16]. For tRPS,
the required concentration for particle analysis increased as the particle
volume decreased. Consequently, 203 nm beads were analyzed at
9.1 × 107/ml–2.9 × 109/ml, whereas 115 nm particles were analyzed
at 3.6 × 108/ml–2.3 × 1010/ml. hFC allows accurate quantiﬁcation at
lower particle concentrations (a range of 4.6 × 106/ml–7.3 × 107/ml
was analyzed in the current study). Our recent data indicate that
concentrations up to 1.0 × 109/ml can be reliably measured with hFC
(manuscript in submission).
We identiﬁed the NTA camera level and detection threshold to be
signiﬁcant factors in the quantiﬁcation of liposomes (Fig. 1C). In
contrast, the absolute differences induced by changing these variable
settings were less prominent for quantiﬁcation of EVs (Fig. 1D). This
may be a result of the relatively higher light-scattering properties of
EVs (due to the presence of surface/luminal proteins and/or m(i)
RNAs), combined with increased heterogeneity in this population,
which may make NTA-based detection of EVs less sensitive to differ-
ences in settings as compared to the detection of homogeneous lipo-
somes. Besides the empty liposomes used in this study, liposomes
engineered to contain proteins and/or nucleic acids show morestructural resemblance with EV and quantiﬁcation of such particles
may accordingly be less sensitive to NTA detection thresholding.
Our tRPS analyses showed inter-experimental variation in the
sensitivity of liposome and EV detection (Fig. 2C and E), which translated
into differences in concentration measurement. This sensitivity of tRPS-
basedmeasurements is determined by the size of the smallest detectable
particle. For quantiﬁcation of homogeneous particle populations of a
known size, such as calibration beads, the most suitable nanopore setup
for detection of all particles can easily be selected. However, for samples
with an unknown size-distribution (e.g. EVs) this ismore difﬁcult and the
obtained size detection range may be insufﬁcient for detection of all
particles. Besides this, we also noted slight differences in tRPS-based
concentration measurements (up to ~1.4 fold) between set-ups in
which the liposome size-distribution proﬁles and detections limits were
similar (Fig. 2C). We hypothesize that subtle differences in nanopore
size due to batch variations and nanopore longevity could have caused
these variations in particle quantiﬁcation. The observed differences stress
the importance of comparing samples using exactly the same tRPS setup.
Electro-kinetic forces were recently suggested [39] to inﬂuence the
movement of particles through smaller tRPS nanopore. In case particles
possess a different surface-charge compared to the polystyrene calibra-
tion particles, one of the two particle types may be more likely to pass
through the nanopore. Since thismay cause inaccuracy in the calculated
particle/minute to concentration calculation, the manufacturer
suggested to perform quantiﬁcations at two or more pressure levels,
after which the tRPS software can determine a surface-charge corrected
concentration. Since we observed no difference in the measured
liposome concentration at two different pressure levels (Fig. 2D), we
conclude that electrokinetic forces at these settings do not signiﬁcantly
inﬂuence the quantiﬁcation of particles. The surface charge of the stud-
ied liposomes was−43.0 ± 0.87 mV, which is similar to the reported
surface charge characteristics of EVs [40–42]. Single-pressure tRPS
quantiﬁcations can therefore sufﬁce for accurate EV quantiﬁcations.
The difference in blockade height when measuring the 115 nm calibra-
tion particles at the two pressure settings (Suppl. Fig. S3A, left-panel)
was unexpected, because the applied pressure does not change the par-
ticle volume and nanopore diameter. Implications of this phenomenon
for particle characterization need to be further studied. When compar-
ing the liposome size-distributions obtained by tRPS and NTA (Fig. 2C
and Suppl. Fig. S2C), we conclude that both NTA and tRPS allowed
detection of liposomes as small as 55–60 nm in size, which for NTA is
the theoretical lower limit of liposome detection, limited by the r.i. of
the particle [16,20].
In contrast to NTA and tRPS, for hFC the threshold for particle
detection is based on ﬂuorescence intensity. Although the sensitivity
for detection is largely improved by the use of high power lasers and
by increasing the dwell time of the vesicles in the laser beam, particles
with low ﬂuorescence intensity (e.g. due to lowPKH67 labeling efﬁcien-
cy or because of small size) may not be detected using this technique.
Furthermore, the removal of unbound ﬂuorescent dye by density gradi-
ent ultracentrifugation can be seen as a time-consuming procedure.
However, the same procedure also allows separation of EVs from
protein aggregates that are abundantly present in culture media and
body ﬂuids. This is essential, since such aggregates can mistakenly be
recorded as vesicles by the technologies discussed here.
Comparability analysis of the three techniques indicated that
substantially larger differences in quantiﬁcation were obtained for
liposomes, compared to EVs (Fig. 4A andD). In fact, no signiﬁcant differ-
ence in raw concentration estimationwas observed for quantiﬁcation of
EVs by tRPS versus hFC. One potential explanation is that the EVs exhibit
higher ﬂuorescence levels compared to the liposomes, either because
EVs are larger in size and incorporatemore dye or because of differences
in labeling efﬁciency. Differences between the other instruments are
difﬁcult to account for. For both liposome batches and EVs, higher raw
concentration estimations were obtained by NTA compared to tRPS.
We tested whether background particle detection (from the buffer in
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However, measurement of PBS background particles at camera-level 9
and 12 revealed maximum concentrations of only 2.60 × 107/ml and
3.3 × 107/ml, respectively (data not shown), accounting for 3.29%
(L146) and 2.33% (L212) of the measured concentrations of the
liposomes.
So far, only one other study has directly compared NTA, tRPS and
ﬂow cytometry (using a different high-end ﬂow cytometer) by analyz-
ing the size distributions of polystyrene beads and urine-derived EV
[32]. Interestingly, comparable EV quantiﬁcations by NTA and tRPS
were reported, whereas the ﬂow cytometry-based EV quantiﬁcation
was 15 times lower. However, a direct comparison of these data to our
current study is difﬁcult, because a crudepreparation (1550×g centrifu-
gation followed by 0.2 μm ﬁltration) of EVs from a different biological
source (urine) was analyzed and because the ﬂow cytometric measure-
ments in that study were light scatter-based. However, it is interesting
to note that, in contrast to our ﬁndings, EV quantiﬁcations by NTA and
tRPS were found to be comparable. This could imply that the type of
EV and the degree of EV puriﬁcation may also inﬂuence quantiﬁcation
by the different instruments.
Several strategies have previously been suggested to calibrate
particle quantiﬁcation in EV samples. For tRPS we spiked biological
ﬂuids with polystyrene beads of known size and concentration to
improve EV quantiﬁcation accuracy [18]. For NTA, on the contrary,
this approach seems less suitable since the methodology does not
allow for accurate discrimination of particles of interest from beads
with a similar size [17,20,30]. Secondly, spiking a sample with large
(N500 nm) silica beads could lead to over-scattering of the EVs and
skew characterization [20]. An alternative that has been proposed for
NTA calibration is application of a correction factor, based on the
measured concentration of silica beads compared to the expected con-
centration of these beads [17]. Although promising and potentially
valuable for measuring relatively homogenous populations of EVs,
such a calibration method is unsuitable for analysis of the heteroge-
neous EV preparations studied here. AsNTA is less accurate in the detec-
tion of size-based subpopulations [17,20,30], onewould have to apply a
multitude of silica calibration beads, each covering a subpopulation of
EVs and subsequently aggregate analysis of these subpopulations.
More research into the accuracy of such a calibration system will be
essential before it can be broadly applied.
In conclusion, we identiﬁed NTA and tRPS instrument settings
that affect particle quantiﬁcation and showed that the impact of
these parameters on quantiﬁcation varies with the types of nano-
sized particles analyzed (i.e. polystyrene beads, liposomes and
EVs). Our data clearly indicate that absolute quantiﬁcation of EVs
and liposomes substantially differs using the three different technol-
ogies and that a golden standard for quantiﬁcation of such particles is
not available yet. Moreover, our data strongly underline the impor-
tance of technical knowledge of the instruments for correct data in-
terpretation, and plead for awareness of the effects of instrument
settings in case vesicle populations with unknown concentration
and size heterogeneity are measured. Increased understanding of
the possibilities and pitfalls of these technologies will beneﬁt stan-
dardized and large-scale clinical application of (engineered) EVs
and EV mimics in the future.Acknowledgments
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